Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated questionnaires and exams before, during, and after treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Established diagnosis of multiple sclerosis (any subtype) by 2017 McDonald criteria
• Established diagnosis of major depressive disorder (MDD) by DSM-5 criteria
• Eligible for transcranial magnetic stimulation (rTMS) for depression
Locations
United States
Utah
University of Utah Health
RECRUITING
Salt Lake City
Contact Information
Primary
Kathleen Shangraw, MD
kathleen.shangraw@hsc.utah.edu
8015832500
Backup
Trieste Francis
trieste.francis@hsc.utah.edu
Time Frame
Start Date: 2024-01-16
Estimated Completion Date: 2026-01
Participants
Target number of participants: 12
Related Therapeutic Areas
Sponsors
Leads: University of Utah